» Authors » Helena P G Joaquim

Helena P G Joaquim

Explore the profile of Helena P G Joaquim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 140
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa A, Gasparotto Jr A, Garcia A, Pereira C, Lourenco E, Joaquim H
Toxicol Rep . 2025 Feb; 14:101918. PMID: 39917037
Cannabinoids offer a novel pharmacotherapeutic approach and can complement other medications to address unmet clinical needs in numerous patients, which has led to a global increase in the use of...
2.
Serpa M, Doshi J, Joaquim H, Vieira E, Erus G, Chaim-Avancini T, et al.
Schizophr Res . 2023 May; 257:5-18. PMID: 37230043
Objectives: Schizophrenia-related psychosis is associated with abnormalities in white matter (WM) microstructure and structural brain dysconnectivity. However, the pathological process underlying such changes is unknown. We sought to investigate the...
3.
Costa A, Joaquim H, Pedrazzi J, Pain A, Duque G, Aprahamian I
Brain Sci . 2022 Dec; 12(12). PMID: 36552056
The use of cannabinoids as therapeutic drugs has increased among aging populations recently. Age-related changes in the endogenous cannabinoid system could influence the effects of therapies that target the cannabinoid...
4.
Joaquim H, Costa A, Pereira C, Talib L, Bilt M, Loch A, et al.
Eur J Neurosci . 2021 Oct; 55(4):1079-1087. PMID: 34716624
The onset of frank psychosis is usually preceded by a prodromal phase characterized by attenuated psychotic symptoms. Currently, research on schizophrenia prodromal phase (ultra-high risk for psychosis [UHR]) has focused...
5.
Pereira C, Costa A, Joaquim H, Talib L, van de Bilt M, Loch A, et al.
World J Biol Psychiatry . 2021 Sep; 23(3):236-241. PMID: 34547958
Background: The identification of Ultra-High Risk (UHR) individuals is thought to be useful for early intervention to improve psychosis outcomes. However, transition rates vary widely, and there is an effort...
6.
Talib L, Costa A, Joaquim H, Pereira C, van de Bilt M, Loch A, et al.
Eur Arch Psychiatry Clin Neurosci . 2021 Mar; 271(8):1593-1599. PMID: 33677687
Phospholipase A is the main enzyme in the metabolism of membrane phospholipids. It comprises a family of enzymes divided into iPLA, cPLA and sPLA. Studies have reported increased PLA activity...
7.
Joaquim H, Costa A, Talib L, Dethloff F, Serpa M, Zanetti M, et al.
Front Psychiatry . 2020 Jun; 11:496. PMID: 32581873
Introduction: The first symptoms of psychosis are frequently shared amongst several neuropsychiatry disorders, which makes the differentiation by clinical diagnosis challenging. Early recognition of symptoms is important in the management...
8.
Loureiro J, Stella F, Pais M, Radanovic M, Canineu P, Joaquim H, et al.
J Affect Disord . 2020 Jun; 272:409-416. PMID: 32553384
Background: Cognitive impairment is a common feature of late-life depression (LLD). Early studies using Alzheimer's disease (AD) biomarkers inferred a biological link between AD pathology and LLD, but recent findings...
9.
Joaquim H, Costa A, Serpa M, Talib L, Gattaz W
Eur Arch Psychiatry Clin Neurosci . 2019 Aug; 270(4):489-494. PMID: 31372726
The cellular and molecular mechanisms underlying onset and development of schizophrenia have not yet been completely elucidated, but the association of disturbed neuroplasticity and inflammation has gained particular relevance recently....
10.
Costa A, Joaquim H, Forlenza O, Gattaz W, Talib L
Eur Arch Psychiatry Clin Neurosci . 2019 Jun; 270(4):483-488. PMID: 31218445
The metabolomic profile of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) may suggest potential diagnostic biomarkers and provide information on the pathophysiology of dementia. Our aim was...